Questions of Treatment and More

There are so many issues being looked at, talked about, studied.

Here are some more:


Recurrence or New Primary?

Dr. Dava F. Gerard answers a question

Bca in Surgical Scars
Reducing the Risk of Locally Recurrent Breast Cancer
Patient Empowerment Improves Treatment

The European view 9/00

Dr. Charles Vogel Updates:Treatments

Talk at the SHARE office 10/13/00 Conventional choices for metastatic disease

Exemestane-Info from Germany
Arimidex(Anastrozole) as First-Line Therapy
HERCEPTIN Issues

Journal of Clinical Oncology November 2000

Discrepancies in Tests/False Positives
Wait 22 weeks Before Using Anthracylines After Herceptin
From HER2 to Herceptin (Trastuzumab)
Contra-indications for Herceptin Use
WARNING: Taxol & Herceptin (Metastatic Breast Cancer)
Assay Predicts Response to Herceptin Therapy
Some Recent Statements on Her2/Herceptin
Herceptin & Central Nervous System Mets
Platinum-Taxane w/Herceptin
Docetaxol &Trastuzumab BIG BENEFITS
Gamma-linolenic Acid BOOSTS Effectiveness of Herceptin
Adjuvant Herceptin: Am Soc of Breast Disease Statement
Trastuzumab-Resistant HER2-Driven Breast CaCells Sensitive to Epigallocatechin-3 Gallate
Olive Oil Cuts Levels of Her-2/neu
Am College Pathology & ASCO Set Standards for HER2neu Testing
Lumpec/Mastect: Doctor's Gender Matters

Study, Arch Surg, 2001

Treatment Issues in 1901

JAMA, March 2001 Actual article from 1901

C-GSF & CA15-3 (false positives)

Watch out for false positives

Risk of Colorectal Ca After Breast Ca

Lancet,March 2001

Accelerated Radiotherapy

Study in J Clinical Oncology, April 2001

Tumor Bed Irradiation:24-48 hours
Targeted Intra-operative RT (TARGIT)
Node Negative Breast Cancer

7th International Conference on Adjuvant Breast Therapy, 4/01

Systemic Treatment for Node-Negative Patients
Node Positive Breast Cancer (Consensus)

7th International Conference on Adjuvant Breast Cancer Therapy 4/01

References
Vita D Analogue Enhances Response to Chemo/Radiation

Cancer Chemotherapy and Pharmacology, May, 2001

Vitamin D3 & ILX 23-7553 & RTx in Breast Tumor cells
Vitamin D3 & Analogues as Adjunct to Chemo/RTx
Vit D 3 Analog EB 1089 Enhances Adriamycin Effects
RU486 Inhibits Proliferation & Metastasis

Int'l J of Cancer, May 2001

Enrolling for Clinical Trial on RU486-Mifepristone
Risk/Benefit Different for Patients w/Metastatic Disease

Intro to article in Oncology 5/9/01

Chips Predict  Tumor Aggression/Treament

Nature, 1/02

Mitomycin Should Not be Given for Locally Advanced Bca

The Breast, 2/02

ATM gene: Avoid Radiation

Intl J Radiation Oncology, Biology and Physics, 3/02

Hormone Therapy Versus Chemotherapy

European Breast Cancer Conference 3/02

Doxorubicin Cardiotoxi & Radionucl Monitoring

J Nucl Cardiol, 4/03

RFA and Complete Necrosis of Invasive Bca

Doctor's Guide, 2001

High Intensity Focused Ultrasound Ablation-Local BCa
Oncological Drug Advisory Committee meets on Avastin

July 20, 2010

Testimony of Roberta Gelb SHARELeaders
Fran Visco, President NBCC Letter on Avastin

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.